The Case for Autoimmunity in the Etiology of Schizophrenia

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pharmacotherapy

• Publication date

  2008-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1592/phco.28.6.730PMID 18503401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Thyrotropin Receptor in Graves' Disease

  2007cited by this paper
• Decreased T cellular immune response in schizophrenic patients.

  2007cited by this paper
• Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia

  2007cited by this paper
• The Genetic Basis of Thyroid Autoimmunity

  2007cited by this paper
• Genetic Associations between Delusional Disorder and Paranoid Schizophrenia: A Novel Etiologic Approach

  2006cited by this paper
• Molecular genetic studies of schizophrenia

  2006cited by this paper
• The role of HLA-G in cytokine homeostasis during early pregnancy complicated with maternal infections: a novel etiopathological approach to the neurodevelopmental understanding of schizophrenia.

  2006cited by this paper
• IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia

  2006cited by this paper
• Regulation of m1 muscarinic receptors and nNOS mRNA levels by autoantibodies from schizophrenic patients.

  2006cited by this paper
• An autoimmune or an inflammatory process in patients with schizophrenia, schizoaffective disorder, and in their biological relatives.

  2006cited by this paper
• Cytomegalovirus and Schizophrenia

  2006cited by this paper
• Failure to detect dopamine receptor IgG autoantibodies in sera of schizophrenic patients

  2005cited by this paper
• A Systematic Review of the Prevalence of Schizophrenia

  2005cited by this paper
• Fetal Environment and Schizophrenia

  2005cited by this paper
• In Vivo Assessment of the Relative Contributions of Deletion, Anergy, and Editing to B Cell Self-Tolerance1

  2005cited by this paper
• The inheritance of intermediate phenotypes for schizophrenia

  2005cited by this paper
• Several genes in the extended human MHC contribute to predisposition to autoimmune diseases.

  2005influential reference
• Anticardiolipin antibodies are elevated in drug-free, multiply affected families with schizophrenia

  2005cited by this paper
• Diagnostic Tests for Rheumatic Disease: Clinical Utility Revisited

  2005cited by this paper
• CAT 53: a protein phosphatase 1 nuclear targeting subunit encoded in the MHC Class I region strongly expressed in regions of the brain involved in memory, learning, and Alzheimer's disease.

  2005cited by this paper
• Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia

  2005cited by this paper
• Human leukocyte antigen‐DQB1 alleles are not associated with schizophrenia in Kuwaiti Arabs

  2004cited by this paper
• Leukocyte Elastase and Autoantibodies to Nerve Growth Factor in the Acute Phase of Schizophrenia and their Relationship to Symptomatology

  2004cited by this paper
• Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients' sera

  2004cited by this paper
• Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia

  2004cited by this paper
• Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia.

  2004cited by this paper
• Membrane phospholipids and cytokine interaction in schizophrenia.

  2004cited by this paper
• Significant frequency deviation of the class I polymorphism HLA-A10 in schizophrenic patients

  2003cited by this paper
• Autoantibodies to serotonin in serum of patients with psychiatric disorders.

  2003cited by this paper
• The influence of olanzapine on immune cells in patients with schizophrenia.

  2003cited by this paper
• Studies characterizing 60 kda autoantibodies in subjects with schizophrenia.

  2003cited by this paper
• Post-streptococcal autoimmune disorders of the central nervous system.

  2003cited by this paper
• Platelet-Associated Antibodies Mediate Protective Autoimmune Response in Schizophrenia

  2003cited by this paper
• Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders.

  2003cited by this paper
• Human leukocyte antigen-A specificities and its relation with season of birth in Japanese patients with schizophrenia.

  2002cited by this paper
• Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.

  2002cited by this paper
• Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.

  2002cited by this paper
• Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA1-, DQB1-, and DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophrenia.

  2002cited by this paper
• HLA class I distribution in Japanese patients with schizophrenia.

  2002cited by this paper
• Antibodies Against Cerebral M1 Cholinergic Muscarinic Receptor from Schizophrenic Patients: Molecular Interaction1

  2002cited by this paper
• Identification of antibodies to heat shock proteins 90 kDa and 70 kDa in patients with schizophrenia.

  2001cited by this paper
• Handedness and immune function.

  2001cited by this paper
• Immune related genetic polymorphisms and schizophrenia among the Chinese.

  2001influential reference
• Transmission disequilibrium analysis of HLA class II DRB1, DQA1, DQB1 and DPB1 polymorphisms in schizophrenia using family trios from a Han Chinese population.

  2001cited by this paper
• Th1 and Th2 responses: what are they?

  2000cited by this paper
• Schizophrenia and HLA: No association with PCR-SSOP typed classical loci in a large Irish familial sample.

  1999cited by this paper
• Elevated interleukin-6 in schizophrenia

  1999cited by this paper
• Introduction to immunology and autoimmunity.

  1999influential reference
• Antibodies to heat shock proteins in schizophrenic patients: implications for the mechanism of the disease.

  1999cited by this paper
• Antibodies to neuroblastoma cell line proteins in patients with schizophrenia.

  1998cited by this paper
• Autoantibodies against 60-kDa heat shock protein in schizophrenia

  1998cited by this paper
• Effects of Clozapine on In Vitro Immune Parameters: A Longitudinal Study in Clozapine-Treated Schizophrenic Patients

  1998cited by this paper
• HLA antigens in childhood onset schizophrenia.

  1998cited by this paper
• Antibrain antibodies in mental disorder: no evidence for antibodies against synaptic membranes

  1998cited by this paper
• Short and long-term immunosuppressive effects of clozapine and haloperidol.

  1997cited by this paper
• Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

  1996cited by this paper
• Differences in the natural autoantibody patterns of patients with schizophrenia and normal individuals.

  1996cited by this paper
• HLA antigens in schizophrenia and mood disorders.

  1996cited by this paper
• Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease?

  1996cited by this paper
• No evidence for autoimmunity in schizophrenia.

  1996cited by this paper
• Impaired mitogen (PHA) responsiveness and increased autoantibodies in Caucasian schizophrenic patients with the HLA B8/DR3 phenotype.

  1995cited by this paper
• Autoantibodies in the diagnosis of systemic rheumatic diseases.

  1995cited by this paper
• Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients

  1995cited by this paper
• Specific IgA antibody increases in schizophrenia.

  1995cited by this paper
• Autoantibodies in the diagnosis of systemicrheumatic diseases

  1995cited by this paper
• Increased prevalence of antibrain antibodies in the sera from schizophrenic patients.

  1994cited by this paper
• A preliminary prospective study on natural autoantibodies and the response of untreated schizophrenic patients to neuroleptics.

  1994cited by this paper
• Handedness and allergic response.

  1994cited by this paper
• Serum antibodies to nicotinic acetylcholine receptors in schizophrenic patients.

  1994cited by this paper
• DSM-IV: Diagnostic and Statistical Manual of Mental Disorders

  1994cited by this paper
• Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness.

  1994cited by this paper
• Platelets from schizophrenic patients bear autoimmune antibodies that inhibit dopamine uptake

  1993cited by this paper
• Increased anti-Sm antibodies in schizophrenic patients and their families.

  1993cited by this paper
• Autoantibodies to DNA in multicase families with schizophrenia.

  1993cited by this paper
• Antinuclear and gastric parietal cell autoantibodies in schizophrenic patients.

  1992cited by this paper
• Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production.

  1992cited by this paper
• Left-handed first-episode, neuroleptic-naive schizophrenic patients have a higher prevalence of autoantibodies.

  1992cited by this paper
• Ganglioside antibodies in schizophrenia and major depression.

  1992cited by this paper
• The prevalence of autoantibodies among right and left handed schizophrenic patients and control subjects.

  1992cited by this paper
• Autoantibodies to DNA in multicase families with schizophrenia

  1991cited by this paper
• Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients.

  1989cited by this paper
• Self-tolerance in B lymphocytes.

  1989cited by this paper
• Dopamine-receptor-stimulating autoantibodies: a possible cause of schizophrenia.

  1982cited by this paper
• Left-handedness: association with immune disease, migraine, and developmental learning disorder.

  1982cited by this paper
• Über die Liquordiagnose der Schizophrenien

  1937cited by this paper

• The role of infections and inflammation in schizophrenia: review of the evidence

  2024cites this paper
• Causal relationship between psychiatric disorders and sensorineural hearing loss: A bidirectional two-sample mendelian randomization analysis.

  2024cites this paper
• Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia

  2022cites this paper
• The SFT2D2 gene is associated with the autoimmune pathology of schizophrenia in a Chinese population

  2022cites this paper
• Vitaminlerin psikiyatrideki rolü: Bir gözden geçirme

  2022cites this paper
• Clinical Diagnosis of an Autoimmune Encephalitis Presented as a Manic Episode with Psychotic Symptoms: A Case Report

  2022cites this paper
• Limbic encephalitis due to antineuronal antibodies

  2021cites this paper
• Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders

  2021cites this paper
• Hidden Role of Gut Microbiome Dysbiosis in Schizophrenia: Antipsychotics or Psychobiotics as Therapeutics?

  2021cites this paper
• University of Birmingham Oxidative stress and the pathophysiology and symptom profile of schizophrenia spectrum disorders

  2021cites this paper
• Rare presence of autoantibodies targeting to NMDA and GABAA receptors in schizophrenia patients.

  2021cites this paper
• Anti-PDHA1 antibody is detected in a subset of patients with schizophrenia

  2020cites this paper
• Igg-Dependent Hydrolysis of Myelin Basic Protein of Patients with Different Courses of Schizophrenia

  2020cites this paper
• Neuroendocrinology Letters-Neuro Endocrinol Lett

  2020cites this paper
• Comorbid Psychiatric and Physical Disorders

  2020cites this paper
• Susac Syndrome in a Pre Puberal Femele: Rare Case

  2019cites this paper
• The Link between Thyroid Autoimmunity, Depression and Bipolar Disorder

  2019cites this paper
• Autoimmune Encephalitides.

  2019cites this paper
• Anti‐TSNARE1 IgG plasma levels differ by sex in patients with schizophrenia in a Chinese population

  2019cites this paper
• Role of Infection, Autoimmunity, Atopic Disorders, and the Immune System in Schizophrenia: Evidence from Epidemiological and Genetic Studies.

  2019cites this paper
• [Psycho-immuno-endocrinology of the thyroid gland].

  2018cites this paper
• Selected risk factors for schizophrenia: between the diversity of aetiological models and personalised psychiatry

  2018cites this paper
• Wybrane czynniki ryzyka schizofrenii: pomiędzy różnorodnością modeli etiologicznych a psychiatrią spersonalizowaną

  2018cites this paper
• Study of Novel Autoantibodies in Schizophrenia

  2018cites this paper
• Untargeted screening for novel autoantibodies with prognostic value in first-episode psychosis

  2017cites this paper
• Examining the Causes of Autism

  2017cites this paper
• Anti-NMDA Receptor Encephalitis, Autoimmunity, and Psychosis.

  2016cites this paper
• Anti-NMDA receptor encephalitis, autoimmunity, and psychosis.

  2016cites this paper
• Schizophrenia among patients with systemic lupus erythematosus: population-based cross-sectional study

  2016cites this paper
• Autoimmune encephalitis masquerading as psychosis: Diagnostic and therapeutic challenge

  2015cites this paper
• The Autoimmune and Infectious Etiological Factors of a Subset of Schizophrenia

  2015cites this paper
• The Role of Infections and Autoimmune Diseases for Schizophrenia and Depression: Findings from Large-Scale Epidemiological Studies

  2015cites this paper
• The investigation of the HLA system and wheat gluten in determining risk of schizophrenia

  2015cites this paper
• The epidemiologic evidence linking autoimmune diseases and psychosis.

  2014cites this paper
• Severe chronic psychosis after allogeneic SCT from a schizophrenic sibling

  2014cites this paper
• Recent Updates in Schizophrenia Genetics

  2013cites this paper
• Autoimmune-induced glutamatergic receptor dysfunctions: conceptual and psychiatric practice implications.

  2013cites this paper
• The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants

  2013cites this paper
• The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia.

  2013cites this paper
• Anti-brain autoantibodies in the serum of schizophrenic patients: a case-control study.

  2013cites this paper
• Relationship Between Schizophrenia and Diabetes Mellitus: Consideration Based on Physiogenomics Data

  2013cites this paper
• Association between antibodies to multiple infectious and food antigens and new onset schizophrenia among US military personnel.

  2013cites this paper
• Call for case histories of BMT in patients with coincident schizophrenia

  2013cites this paper
• Inflammation theories in psychotic disorders: a critical review.

  2013influential citation
• Call for case histories of BMT in patients with coincident schizophrenia

  2013cites this paper
• Registre local d'encéphalites non infectieuses : de leurs descriptions à la proposition d'un algorithme de prise en charge

  2012cites this paper
• Autoimmune diseases and infections as risk factors for schizophrenia

  2012cites this paper
• Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis.

  2012cites this paper
• Schizophrenia and the immune system: pathophysiology, prevention, and treatment.

  2012cites this paper
• Low serum vitamin D concentrations in patients with schizophrenia.

  2012cites this paper
• The major histocompatibility complex and autism spectrum disorder

  2012cites this paper
• Comparative immunogenetics of autism and schizophrenia

  2011cites this paper
• Study of HLA Class I gene in Indian schizophrenic patients of Siliguri, West Bengal.

  2011cites this paper
• The emerging link between autoimmune disorders and neuropsychiatric disease.

  2011cites this paper
• Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia.

  2011cites this paper
• The emergence of a new science of the mind: immunology benefits the mind

  2010cites this paper
• Psychiatric manifestations of paraneoplastic disorders.

  2010cites this paper
• Open letter to the Editor

  2010cites this paper
• Biological mechanisms behind clozapine- induced agranulocytosis

  2009cites this paper
• Markers of vulnerability in schizophrenia

  2009cites this paper